Summary of Changes

1. Updates to IFI wound epidemiology to include surgical and wound healing outcomes
2. Addition of pan-fungal PCR as a potential rapid molecular diagnostic modality
3. Updates on the use of IV voriconazole in those with impaired renal function
4. Updates on posaconazole administration
5. Addition of isavuconazole as a mold active triazole
6. Addition of tissue sample handling considerations to increase culture yield of fungi (i.e. Mucor)
7. Updated Jul 2021 with the Dakin’s half-strength solution